L M Dembry
Overview
Explore the profile of L M Dembry including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
234
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nelson M, Bizzarro M, Dembry L, Baltimore R, Gallagher P
J Perinatol
. 2014 Jul;
34(9):653-5.
PMID: 25010223
The REDUCE MRSA Trial (Randomized Evaluation of Decolonization vs Universal Clearance to Eliminate Methicillin-Resistant Staphylococcus aureus), a large multicenter, randomized controlled trial in adult intensive care units (ICUs), found universal...
2.
Yuan C, Dembry L, Higa B, Fu M, Wang H, Bradley E
J Hosp Infect
. 2008 Nov;
71(2):157-62.
PMID: 19013685
Hand hygiene is considered one of the most important infection control measures for preventing healthcare-associated infections. However, compliance rates with recommended hand hygiene practices in hospitals remain low. Previous literature...
3.
Pashman J, Bradley E, Wang H, Higa B, Fu M, Dembry L
J Hosp Infect
. 2007 Jun;
66(3):249-54.
PMID: 17544167
Effective hand hygiene practice in a clinical healthcare setting is the most effective means to prevent, control and reduce healthcare-associated infections. Despite the introduction of hand hygiene practices and targeted...
4.
Bassetti M, Farrel P, Callan D, Topal J, Dembry L
Int J Antimicrob Agents
. 2003 Jun;
21(6):593-4.
PMID: 12791477
No abstract available.
5.
Bassetti M, Dembry L, Farrel P, Callan D, Andriole V
Diagn Microbiol Infect Dis
. 2001 Dec;
41(3):143-8.
PMID: 11750168
Gatifloxacin is a new 8-methoxy fluoroquinolone. The in-vitro antibacterial activity of gatifloxacin was compared to that of ciprofloxacin, ceftriaxone, imipenem, piperacillin/tazobactam and amoxicillin/clavulanic acid against 165 streptococcal isolates, 369 staphylococcal...
6.
Almuneef M, Baltimore R, Farrel P, Dembry L
Clin Infect Dis
. 2001 Feb;
32(2):220-7.
PMID: 11170911
Molecular typing techniques have been used in outbreak investigations. In this study, molecular typing techniques were used to track the spread of gram-negative rods (GNRs) in a neonatal intensive care...
7.
Weinstein J, Mazon D, Pantelick E, Dembry L, Hierholzer Jr W
Infect Control Hosp Epidemiol
. 1999 Aug;
20(8):543-8.
PMID: 10466554
Objective: To evaluate the usefulness of repeated prevalence surveys to determine trends in the rates of nosocomial infections and to detect changes in risk factors (e.g., use of invasive devices)...
8.
Armstrong L, Dembry L, Rainey P, Russi M, Khan A, Fischer S, et al.
Infect Control Hosp Epidemiol
. 1999 Apr;
20(3):176-82.
PMID: 10100543
Objective: To describe the hospital precautions used to isolate a Sabiá virus (arenavirus: Arenaviridae)-infected patient in a US hospital and to protect hospital staff and visitors. Design: Investigation of a...
9.
Dembry L, Roberts J, Schock K, Marino S, Farrel P, Andriole V
Diagn Microbiol Infect Dis
. 1998 May;
31(1):301-11.
PMID: 9597391
The in vitro activity of trovafloxacin against 721 Gram-negative and 498 Gram-positive organisms was determined by the standard microdilution broth method using commercially prepared frozen microtiter plates. The activity of...
10.
Vazquez J, Dembry L, Sanchez V, Vazquez M, Sobel J, Dmuchowski C, et al.
J Clin Microbiol
. 1998 Feb;
36(2):421-6.
PMID: 9466752
Candida glabrata has emerged as an important nosocomial pathogen, yet little is known about its epidemiology. We prospectively followed 98 patients admitted to a medical intensive care unit and the...